Background. To investigate factors associated with climacteric symptoms and the use of hormone replacement therapy (HRT). Methods. A random sample of women aged 46, 50, 54, 58 and 62 years resident in Gö teborg, Sweden (nΩ5,990) were invited by letter to complete a postal questionnaire concerning the menopause and HRT use. Results. The response rate was 76% (nΩ4,504). Women with a higher education, who exercised regularly and who had regular spare-time activities felt better and had fewer climacteric complaints (p∞0.001) compared to lower educated women, women who exercised infrequently and women who had no spare-time activities. Climacteric symptoms were associated with dryness symptoms (dry eyes, skin, hair and mouth), bilateral salpingo-oophorectomy (SOE), use of psychotropical drugs and use of alternative remedies, previous hysterectomy and fulltime occupation. Stepwise multiple regression analysis showed significant correlations between vasomotor symptoms and various dryness symptoms, no menstrual periods and use of alternative remedies. Current HRT-users (13%) had used estrogens for 4.0 years and past users (14%) for 4.3 years. A correlation (p∞0.005) was found between HRT use and previous use of contraceptive pills, use of alternative remedies and hysterectomy. Education, occupation and the frequency of exercise did not influence the prevalence of HRT use. Conclusions. This study has shown that the experience of climacteric symptoms and wellbeing is associated with many different factors. Women with a higher education and those who exercised regularly were more often symptom-free. HRT use was associated with previous use of contraceptive pills, use of alternative remedies and hysterectomy.
There is general agreement from both cross-sectional and longitudinal studies that 50-70% of postmenopausal women experience hot flushes and night sweats of varying severity (1, 2) , and that approximately 20% still have climacteric complaints even 10 to 20 years after the menopause (3) . Other symptoms which have been reported to be associated with the postmenopausal period are
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C Acta Obstet Gynecol Scand 79 (2000) insomnia, depression and irritability, muscle and joint pain, urogenital symptoms and loss of libido (4) . Serum levels of sex steroids and pituitary hormones have not been reported to correlate with either the degree or the duration of vasomotor symptoms (1) . Instead socio-demographic factors such as education, profession, income level and social class have been found to influence the experience of climacteric complaints (4, 5) .
The prevalence of climacteric symptoms and hormone replacement therapy (HRT) and women's experience and opinions regarding the menopause have previously been described in several popula-tion studies (3) (4) (5) (6) (7) (8) (9) (10) . The use of HRT has gradually increased from year to year (6, (9) (10) (11) (12) . The aim of this study was to investigate factors associated with climacteric symptoms and the use of HRT in a large random sample of Swedish women between 46 and 62 years of age.
Material and methods
The total female population of women from the birth cohorts 1946, 1942, 1938, 1934 and 1930 resident in the city of Gö teborg at the time of this study was 11, 964 . A sample of 5,990 women i.e. every other woman from these five birth cohorts was obtained at random from the population register. The women were invited by letter to cooperate by completing and returning an enclosed questionnaire which included data on:
(i) sociodemographic variables such as marital status, education, employment, and life style factors such as smoking, alcohol consumption and physical activity;
(ii) general health and reproductive history such as age of menarche and menopause, bleeding problems, use of birth control pills, infertility, number of children, gynecological operations, chronic diseases and medical treatments and (iii) questions relevant to the menopause such as the presence and severity of climacteric symptoms, well-being, hormonal substitution or alternative forms of non-hormonal therapies and the efficacy of different treatment regimens.
If no reply was received additional letters were sent 1 and 3 months after the first one. The response rate was 76% (nΩ4,504). The study was approved by the Ethics Committee, Faculty of Medicine at the University of Gö teborg.
Characteristics of the sample and analysis of the non-respondents
The size of the postal questionnaire sample in relation to the total population in the different birth cohorts was 50.1% (range 48.2-51.9% in the different cohorts). The response rate was in general evenly distributed in the five birth cohorts (range 72.9-78.2%). As the population register includes some basic vital statistics for all the women in the sample, it was possible to compare the non-respondents with the respondents. There were more married or cohabiting women (p∞0.001) among the responders and more single women among the nonresponders. Furthermore, in the group of responders there were more Swedish citizens (p∞0.001) and more foreign nationals in the group of non-responders.
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Symptom scores
The severity of current symptoms (at the time of this cross-sectional study, symptoms during the last week) was assessed by the women themselves in the questionnaire by using a four point rating scale (0Ωno symptoms, 1Ωmild, 2Ωmoderate, 3Ωsevere). The following seven symptoms were assessed: vasomotor symptoms, irritability and depressed mood, insomnia, urinary tract infections, urinary incontinence, muscle and joint pain and loss of libido. Vasomotor symptoms, insomnia and vaginal dryness have been shown to be related to estrogen deficiency (13) and to be relieved by estrogen replacement therapy (14) . Thus, in this investigation of factors influencing the prevalence and severity of climacteric symptoms, only these three previously validated symptoms were included in the analysis. These three symptoms were then included as absentΩ0 or presentΩ1 in the univariate and multiple stepwise analyses. A symptom score was obtained by adding the three individual ratings (range 0-3). Furthermore, the women were requested to report if they were suffering from dry eyes, dry skin, dry hair, dry mouth or vaginal dryness, expressed as absentΩ0 or presentΩ1. The women were in addition asked to assess their general well-being with a visual analog scale (VAS) (15) .
Statistical methods
Statistically significant differences between responders and non-responders were analyzed with Fisher's exact test. Differences between groups were analyzed with Student's t-test or ANOVA (Duncan's multiple range test). Significance tests for correlation were performed with Pitman's permutation test, which is a non-parametric test applicable to discrete as well as continuous distributions. Factors possibly associated with climacteric symptoms and the use of hormone replacement therapy were identified by univariate analyses. The identified factors were then included in a stepwise multiple regression analysis. The following factors were included in the analyses regarding an association with the climacteric symptom score (0-3), VAS score (0-100) and estrogen use (non-use; treatment with low potency estrogens; HRT): age, BMI, frequency of exercise, alcohol use, cigarette smoking, broken wrist, alternative remedies, estrogen treatment, various medical illnesses, free-time activities, education, occupation, years of oral contraceptive use, parity, deliveries, infertility, menstruation, gynecological operations and dryness symptoms.
Results
Prevalence of symptoms
Hot flushes and sweats were most commonly reported among 54-year old women (69%) and one third suffered from moderate to severe complaints. In the 62-year old group every other woman still experienced some vasomotor symptoms and 22% rated them as moderate to severe. Depression and irritability were more evenly distributed in the different birth cohorts and 43% of the women had no current symptoms. Sleeping problems were reported by 52% of the women and increased with age. Current lack of sexual desire was reported by 37%.
The correlation between the three validated climacteric symptoms (score 0-3) and other factors, possibly related to the menopause, is illustrated in Table I . There was a significant trend (p∞0.0005) of increased scores of irritability and depressed mood, muscle and joint pain and loss of libido with an increasing climacteric symptom score. Furthermore, there was a parallel increase in dryness symptoms from the eyes, skin, hair and mouth and this score. HRT use was also associated with a higher symptom score.
Factors correlated to climacteric symptoms
The results of the univariate analysis indicated a significant correlation (p∞0.0005) between a high symptom score and full-time occupation, dryness symptoms, use of psychotropical drugs, use of alternative remedies, hysterectomy, bilateral salpingo-oophorectomy (SOE), urinary incontinence operation, higher BMI and high levels on the VAS score of well-being (i.e feeling bad). A low symptom score was correlated to a high level of education (university or college), regular free-time activities and regular exercise. The same correlation Table I . A symptom score (0-3) for three validated climacteric symptoms i.e. hot flushes and sweats, insomnia and vaginal dryness (graded by the women as 0Ωabsent or 1Ωpresent), correlated to irritability and depressed mood, muscle and joint pain and loss of libido (graded as 0Ωnone, 1Ωmild, 2Ωmoderate and 3Ωsevere symptoms), different dryness symptoms and HRT use (graded as 0Ωabsent or 1Ωpresent Statistical analysis with Pitman's permutation test of trends was used (p∞0.0005Ω***).
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pattern was found irrespective of the woman's age or the presence of HRT use, which were included as background variables in this analysis. A greater feeling of well-being (assessed by VAS), irrespective of the use or non-use of estrogens, was positively correlated to a high level of education (university or college) and frequent exercise habits (once a week or more).
The mean values of the symptom scores and the VAS scores were further analyzed and compared in the different age groups (Table II) . The highest mean symptom score was recorded in the 54 and 58 years birth cohorts. Women who complained of dry eyes, dry skin, dry hair and a dry mouth and women with a BMI±30 were found to have both a high symptom score and a high VAS score (i.e. feeling bad) compared to women without dry symptoms and BMI∞20 (p∞0.001). A higher level of education, full-time occupation and frequent exercise habits were associated with a low symptom score as well as a low VAS score. Both scores showed a high level in women who no longer had regular menstruation and who had undergone hysterectomy, bilateral SOE and incontinence operations compared to pre-menopausal and non-operated women. The highest absolute value of the scores were found among women using alternative remedies, psychotropical drugs, those with dry mouth and with breast cancer as well as early retirement from work.
A stepwise multiple regression analysis was performed (Table III) in order to further investigate factors associated with climacteric symptoms, well-being and HRT use. A high climacteric symptom score was significantly associated with various dryness symptoms (dry mouth, skin and hair), no menstrual periods and the use of alternative remedies. The VAS score (well-being) was associated with occupation, dry mouth and skin, BMI and cardiovascular diseases. 
Prevalence and duration of estrogen use
The prevalence of current estrogen use, including both medium (13%) and low potency (8%) estro- gens, was 21% (range 6-29%) and 34% were pastusers (Table IV) . The highest HRT use was found among 54-year old women (24%). The use of low potency estrogens increased in a linear fashion with increasing age and the maximum prevalence was recorded in 62-year old women (19%). The use of HRT among women who had undergone hysterectomy and/or oophorectomy was 30% compared to 16% (p∞0.001) in women who had not undergone surgery. The mean duration of current HRT use was 4.0 years and 4.3 years for past use.
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Factors influencing estrogen use
There were no significant differences in the prevalence of HRT use or the duration of therapy between women of foreign nationality compared to Swedish women in the population sample. The use of both low and medium-potent estrogens was evenly distributed among the women irrespective of their level of education. The same prevalence of HRT use was found among university educated women (18%) as in the group with only primary school education (16%). There was no difference in HRT use between women who exercised regularly i.e ±1/week (18% users and 70% non-users) compared to those who never exercised (17% users and 75% non-users). Among the HRT users, 32% exercised ±1/ week (the same for non-users) and 20% never exercised (23% non-users). HRT users had a lower body weight and a lower BMI compared to non-users in all age-groups, except for the 46-years old cohort.
In a univariate correlation analysis of current estrogen use with various other factors a significant correlation (p∞0.005) was found with previous use of oral contraceptives, previous use of alternative remedies, a history of various gynecological operations (hysterectomy, bilateral SOE, urinary incontinence) and having hypothyreosis. The use of tranquilizers and antidepressive medicines was correlated (p∞0.0001) to non-use of HRT.
In a multiple regression analysis (Table III) frequent current estrogen use was significantly associated with no menstrual periods, use of alternative remedies, previous use of oral contraceptives and hysterectomy and SOE-surgery.
Discussion
The prevalence and severity of climacteric symptoms among middle-aged women reported in earlier studies has varied considerably (5, 13). The probable explanation for this wide variation is that many studies have been based on selected groups of women and different definitions of the symp-C Acta Obstet Gynecol Scand 79 (2000) toms have been used (16) . The Swedish Population Register, which provides up-to-date information on the population living in the country at any given time, is suitable for epidemiological studies as it permits the selection of a random sample from the total population. The response rate in the present study was 76%, which is similar to other epidemiological studies of women in the same age groups in Sweden (3, 6) . There were only minor differences between the characteristics of the responders compared to the non-responders. Hence the results appear to be valid for women 46 to 62 years of age resident in Gö teborg. However, the limitations of cross-sectional studies should be recognized and have been described previously (17) .
The women in the present study who exercised frequently had less vasomotor symptoms and a better well-being. This is consistent with the findings of Hammar et al. (18) who reported less climacteric symptoms among regularly exercising women compared to non-exercising. The causal mechanism of vasomotor symptoms is not yet fully understood but a lability of the thermoregulatary center in the hypothalamus appears to be involved. Changes in neurotransmittor activity e.g. endorphins, noradrenaline and catechol-estrogens have been suggested to be responsible for the differences (18) .
Regular physical activity, as well as acupuncture, have been shown to affect the level of hypothalamic-endorphin (19) . In contrast, Guthrie et al. did not find any correlation between physical activity and menopausal symptoms or psychological wellbeing (20) . However a significant association was noted in this study between regular exercise and better self-rated health as well as a lower BMI.
In the present study there was a correlation between a high climacteric symptom score and having a hysterectomy or bilateral SOE, indicating that the rapid reduction in estrogen level in operated women is associated with more severe symptoms (2, 21) . Correlation analysis of the climacteric symptom score demonstrated a significant association with dryness symptoms from the eyes, skin, mouth and hair. These findings confirm the results of other investigators (22, 23) , who have shown a correlation between the menopause and dryness in the mouth and eyes.
Women in the present study with a lower level of education, occupation and exercise activity, as well as few free-time activities, had more climacteric symptoms, which is in agreement with earlier reports on the influence of sociodemographic factors (4, 5) . There was also a correlation between vasomotor symptoms and the use of psychotropical drugs (tranquilizers, sleeping pills, antidepressives) and different natural remedies. This is in agreement with the previously reported high prevalence of using tranquilizers and antidepressives in women at the time of the menopause (24) .
Obese postmenopausal women have been found to have an increased peripheral conversion of androstenedione to estrone in adipose tissue compared to non-obese women. This might be associated with fewer climacteric symptoms in overweight women. Some investigators have reported that women with low weight/BMI had more hot flushes at the time of the menopause (25) but others have found the opposite correlation (26, 27) . A higher BMI was correlated with a higher climacteric symptom score in the present study. One reason could be that overweight women may sweat more often because of their extra weight load, and obesity is also associated with less exercise and poor general condition. Overweight might also be viewed as a lifestyle factor, with less concern about health and lower self-esteem in psychosocial terms (28) , which may have influenced the motivation to use HRT. Obesity is further correlated to several illnesses, such as non-insulin dependent diabetes mellitus, hypertension and CVD, that might be associated with a lower HRT use.
Several studies have noted a correlation between a high level of education and HRT use (29) . The general education level in Sweden is high, especially in the younger birth cohorts and 80% of all the women in the population sample were working full-time or part-time. We found no difference in the use of HRT in women representing different education levels or occupational categories, which is probably explained by the uniform social pattern in Sweden together with the welfare system, which includes low costs of medications. The same pattern of HRT use has been reported in another Swedish study (7) .
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Former birth control pill users were found to be more often HRT users in the present study, which is in agreement with the findings in a recent Swedish study (9) . A probable explanation might be that these women had a positive experience of taking contraceptive pills, making it easier and more natural for them to use and accept HRT. There was also a correlation between the use of alternative remedies and current HRT use, indicating that women who had tried these therapies were not satisfied with their effect on climacteric symptoms and had subsequently changed to HRT (10) .
In all the birth cohorts, except the youngest one, HRT users had a lower BMI than non-users. It has been reported that women sometimes refrain from HRT because of fear of weight gain (30) but no such correlation was found, although a cross-sectional study is not the best instrument for evaluating weight increase during HRT. A higher prevalence of HRT use was found among women who had undergone a hysterectomy and/or bilateral SOE in the present study confirming the results of other investigators (21, 31) . Furthermore, the duration of estrogen treatment was longer, about 4 years, than previously reported (9) . A possible improvement in compliance due to a higher acceptance of bleed-free continuous combined estrogenprogestogen regimens may be one possible explanation (32) . It may also reflect a growing positive attitude among women towards long-term HRT to obtain not only the immediate relief of vasomotor symptoms, but also the long-term general health benefits of protection against osteoporosis and cardiovascular diseases.
